AGMBAgomAb Therapeutics NV

Healthcare
$9.05

The financials

AgomAb Therapeutics NV by the numbers

For the full year FY2025, revenue was €1.6M (+32% year on year) and net income −€63M.

Biotechnology

The closest names by size in the same industry

Compare peers
CTNM-1.5%
Contineum Therapeutics, Inc.
TTRX+1.1%
Turn Therapeutics Inc.
BNTC-2.0%
Benitec Biopharma Inc.
SRZN-1.0%
Surrozen, Inc.
ARTV-0.81%
Artiva Biotherapeutics, Inc.
ZURA-4.5%
Zura Bio Ltd